Drugs / Indocynanine Green
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02316795 | Feb 2014 → Jun 2015 | breast cancer, melanoma | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indocynanine Green | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02316795 ↗ |
| Modality | Diagnostic / imaging agent | “This is a infrared fluorescence imaging contrast agent” NCT02316795 ↗ |
| Route | Other | “1.6 mL of 500 micro-molar ICG will be injected periareolarly (for breast cancer) or peri-tumorly (for melanoma)” NCT02316795 ↗ |